Milestone Financial Year 2022 - 23 For Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has achieved the milestone of Rs. 533 crore Revenue & Rs. 100 crore Profit before tax for the first time in a financial year. Company has reported its Best-ever results in a financial year with the highest - Revenue, EBITDA and Net Profit during FY 2023.
SpectronRx Opens European Facility on SCK CEN's Premises
SpectronRx, a radiopharmaceutical contract development and manufacturing organization (RCDMO) and radiopharmaceutical contract manufacturing organization (RCMO) is opening its first European radio labeling facility in Belgium with the aim of helping to supply the region with much needed medical radioisotopes.
Astellas Pharma to Transfer Manufacturing Plant, Business to Delpharm
Astellas Pharma announced that Astellas B.V., Astellas Pharma Europe B.V., and Astellas’ subsidiaries in the Netherlands have decided to sell and transfer the manufacturing plant located in Meppel to Delpharm Industries.
WuXi Biologics Achieves Facility of the Year Award 2023 from ISPE
WuXi Biologics announced that the company has won the operations category of the 2023 Facility of the Year Award (FOYA) from the International Society for Pharmaceutical Engineering (ISPE).
Touchlight Extends DNA Formulating Facility in London
Doggy bone DNA (dbDNA), a patented product of Touchlight, circumvents the technical difficulties involved in effectively mass-producing plasmid DNA.
Beren Therapeutics PBC and Roquette Sign Strategic Investment and Innovation Agreement
Roquette announce a strategic investment with Beren Therapeutics P.B.C.
The Pharmacy and Poisons Board (PPB) of the Kenyan Health Ministry awarded the accreditation, recognising Venus Remedies dedication to quality assurance and international manufacturing standards.
Thermo Fisher Scientific opens sterile drug facility in Singapore
Thermo Fisher Scientific has expanded its sterile manufacturing and research capabilities in the Asia-Pacific region with the opening of a new sterile drug facility in Singapore.
USFDA Inspects Aurobindo Pharma's API Unit, Issues 'Form 483' With Four Observations
On 19 May, Aurobindo Pharma's Unit XIV, an API Non-antibiotic Manufacturing facility situated at Paravada Industrial Area, Anakapalli District got inspected by the United States Food and Drug Administration (USFDA) from 15th May to 19th May 2023, the company stated in an exchange filing on Friday.
GenScript Enlarge Peptide and Oligonucleotide Manufacturing Facility in China
GenScript has been accelerating research efforts by providing high-quality bespoke peptides and peptide libraries with 100% assured quantity.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy